ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,275Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 154

$1.17M Total Retail Price of All Prescriptions

Rank: 16 out of 154

606 Patients Receiving at Least One Drug in Part D
39%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 606 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

4% of this provider’s 606 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

6% of this provider’s 2,704 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$126 was the average price of a prescription from this provider, compared to $130 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
ZOLPIDEM TARTRATE 374 77 1 8
QUETIAPINE FUMARATE 348 123 2 5
TRAZODONE HCL 326 44 3 1
DOXEPIN HCL 319 86 4 40
VENLAFAXINE HCL ER 286 46 5 17
ABILIFY 271 38 6 7
MIRTAZAPINE 269 104 7 11
DIVALPROEX SODIUM ER 260 131 8 13
RISPERIDONE 259 84 9 2
NAMENDA 250 233 10 41
ZIPRASIDONE HCL 220 64 11 18
CYMBALTA 215 43 12 12
IMIPRAMINE HCL 205 55 R 13 85
AMPHETAMINE SALT COMBO 199 40 S2 14 32
NUVIGIL 188 16 10 15 81
CITALOPRAM HBR 187 67 16 4
OLANZAPINE 176 64 17 14
BENZTROPINE MESYLATE 164 57 R 18 3
LITHIUM CARBONATE 153 18 19 16
HYDROXYZINE PAMOATE 151 34 R 20 28
SERTRALINE HCL 146 35 21 10
OXCARBAZEPINE 132 13 22 33
FLUOXETINE HCL 128 0 23 6
PAROXETINE HCL 123 32 24 22
ROPINIROLE HCL 122 39 25 73
LYRICA 117 58 26 86
INVEGA 116 34 27 43
SEROQUEL 114 40 28 25
FLUVOXAMINE MALEATE 107 14 29 59
LAMOTRIGINE 96 0 30 9
ESCITALOPRAM OXALATE 89 18 31 15
LISINOPRIL 87 29 32 66
LEVOTHYROXINE SODIUM 82 64 33 56
PRISTIQ ER 81 12 34 47
DEXTROAMPHETAMINE-AMPHETAMINE 81 0 S2 34 78
SUBOXONE 81 0 34 72
OMEPRAZOLE 77 40 37 69
TOPIRAMATE 74 15 38 34
CHLORPROMAZINE HCL 70 0 39 48
VYVANSE 69 11 S2 40 88
DONEPEZIL HCL 69 46 40 36
AMITRIPTYLINE HCL 61 15 R 42 44
MELOXICAM 56 40 43 97
BUPROPION XL 56 0 43 19
HALOPERIDOL 56 0 43 21
CYCLOBENZAPRINE HCL 55 0 R 46 94
EXELON 55 52 46 76
DIVALPROEX SODIUM 53 23 48 23
GEODON 52 13 49 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.